contour_next_one_logo.png

Trust the accuracy. Trust the light.

Get Your Free* CONTOUR® NEXT ONE

meter with zoom bubble.png
thumbs-up-contour_resized.png

Ascensia Diabetes Care’s most accurate meter yet‡,¤,§

thumbs-up-contour_resized.png

The CONTOUR® NEXT ONE meter results go beyond the minimum Canadian industry standard for blood glucose meters.

target-contour_resized.png

In a clinical study, the CONTOUR® NEXT ONE meter demonstrated 95% of results were within ±8.4% of a lab reading.§

Combine accuracy with ease-of-use.
With one flash of coloured light, the smartLIGHT feature lets you
know whether you’re within, above, or below your target range.

green_nub.png

Within
Target

red_nub.png

Above
Target

yellow_nub.png

Below
Target

 

 

Choose Ascensia Diabetes Care’s
most accurate meter yet‡,¤,§

box_resize.png

 

Get Your Free* CONTOUR® NEXT ONE

Disclaimer:  * with purchase of CONTOUR®NEXT Test Strips † Patient should consult with health care provider before making any changes to blood glucose target ranges, diet, treatment, or exercise decisions. The CONTOUR®NEXT ONE meter pre-set target ranges may be changed using the CONTOUR®DIABETES App. Always review your blood glucose readings in conjunction with the coloured light before making any adjustments to treatment, diet and exercise.

Footnotes:  ‡ Current regulation based on Health Canada recognized ISO 15197:2013 standard requires results within ±15% range, specifically: ≥95% of results must fall within ±0.83 mmol/L for blood glucose concentrations <5.55 mmol/L and within ±15% for blood glucose concentrations ≥5.55 mmol/L. ¤ CONTOUR®NEXT ONE meter meets ±10% accuracy vs. laboratory method, specifically: 97.4% of results within ±10% for blood glucose concentrations ≥5.55 mmol/L, and 100% of results within ±0.56 mmol/L accuracy vs. laboratory method for blood glucose concentrations <5.55 mmol/L. § In a clinical study, conducted in accordance with the requirements of ISO 15197:2013, the CONTOUR®NEXT ONE not only met and exceeded the minimum requirements of the standard but an ad hoc analysis determined where 95% of results fell during the study, which was within ±0.47 mmol/L or ±8.4% of the laboratory reference value for glucose concentrations <5.55 mmol/L or ≥5.55 mmol/L, respectively, when tested via subject obtained capillary fingertip results (patients with diabetes).

References:  1. Christiansen, M. et al. A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology. 2017;11(3):567-573

Ascensia, the Ascensia Diabetes Care logo, Contour, Microlet, Glucofacts, the No Coding logo, and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.

Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google Inc. The BluetoothTM word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license. All other trademarks are the property of their respective owners. For a full list of trademarks click here.

© Copyright 2019 Ascensia Diabetes Care Canada Inc.. Published by Ascensia Diabetes Care Canada Inc, 2920 Matheson Blvd East, Mississauga, Ontario, L4W 5R6, Canada. Tel: 1-800-268-7200

®TM see www.ascensiadiabetes.ca/tm-mc